This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Polonelli, L.
Right arrow Articles by Cailliez, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Polonelli, L.
Right arrow Articles by Cailliez, J. C.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, Mar 1997, 142-146, Vol 4, No. 2
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies

L Polonelli, N Seguy, S Conti, M Gerloni, D Bertolotti, C Cantelli, W Magliani and JC Cailliez
Istituto di Microbiologia, Facolta di Medicina e Chirurgia, Universita degli Studi di Parma, Italy. lucpol@ipruniv.cce.unipr.it

Rat monoclonal yeast killer toxin (KT)-like immunoglobulin M (IgM) anti- idiotypic antibodies (KT-IdAbs) were produced by idiotypic vaccination with a mouse monoclonal antibody (MAb; MAb KT4) that neutralized a Pichia anomala KT characterized by a wide spectrum of antimicrobial activity. The characteristics of the KT-IdAbs were demonstrated by their capacity to compete with the KT to the idiotype of MAb KT4 and to interact with putative KT cell wall receptors (KTRs) of sensitive Candida albicans cells. The internal-image properties of KT-IdAbs were proven by their killer activity against KT-sensitive yeasts. This lethal effect was abolished by prior adsorption of KT-IdAbs with MAb KT4. These findings stressed the potential importance of antibody- mediated immunoprotection against candidiasis and suggested a feasible experimental approach for producing antimicrobial receptor antibodies without purifying the receptor. KT-IdAbs might represent the basis for producing engineered derivatives with a high potential for effective therapeutic antifungal activity.


This article has been cited by other articles:

  • Cenci, E., Pericolini, E., Mencacci, A., Conti, S., Magliani, W., Bistoni, F., Polonelli, L., Vecchiarelli, A. (2006). Modulation of phenotype and function of dendritic cells by a therapeutic synthetic killer peptide. J. Leukoc. Biol. 79: 40-45 [Abstract] [Full Text]  
  • Chaturvedi, A. K., Kavishwar, A., Shiva Keshava, G. B., Shukla, P. K. (2005). Monoclonal Immunoglobulin G1 Directed against Aspergillus fumigatus Cell Wall Glycoprotein Protects against Experimental Murine Aspergillosis. CVI 12: 1063-1068 [Abstract] [Full Text]  
  • Alviano, D. S., Franzen, A. J., Travassos, L. R., Holandino, C., Rozental, S., Ejzemberg, R., Alviano, C. S., Rodrigues, M. L. (2004). Melanin from Fonsecaea pedrosoi Induces Production of Human Antifungal Antibodies and Enhances the Antimicrobial Efficacy of Phagocytes. Infect. Immun. 72: 229-237 [Abstract] [Full Text]  
  • Polonelli, L., Magliani, W., Conti, S., Bracci, L., Lozzi, L., Neri, P., Adriani, D., De Bernardis, F., Cassone, A. (2003). Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis. Infect. Immun. 71: 6205-6212 [Abstract] [Full Text]  
  • Moragues, M. D., Omaetxebarria, M. J., Elguezabal, N., Sevilla, M. J., Conti, S., Polonelli, L., Ponton, J. (2003). A Monoclonal Antibody Directed against a Candida albicans Cell Wall Mannoprotein Exerts Three Anti-C. albicans Activities. Infect. Immun. 71: 5273-5279 [Abstract] [Full Text]  
  • Guyard, C., Seguy, N., Cailliez, J.-C., Drobecq, H., Polonelli, L., Dei-Cas, E., Mercenier, A., Menozzi, F. D. (2002). Characterization of a Williopsis saturnus var. mrakii high molecular weight secreted killer toxin with broad-spectrum antimicrobial activity. J Antimicrob Chemother 49: 961-971 [Abstract] [Full Text]  
  • Cenci, E., Mencacci, A., Spreca, A., Montagnoli, C., Bacci, A., Perruccio, K., Velardi, A., Magliani, W., Conti, S., Polonelli, L., Romani, L. (2002). Protection of Killer Antiidiotypic Antibodies against Early Invasive Aspergillosis in a Murine Model of Allogeneic T-Cell-Depleted Bone Marrow Transplantation. Infect. Immun. 70: 2375-2382 [Abstract] [Full Text]